COVID-19(24) SARS-CoV-2(17) pandemic(16) virus(12) clinical trial(11) drug(10) TMPRSS2(10) approved(9) reducing(9) Vaccine(9) Protein(9) receptor(8) Trial(8) repurposing(8) over(7) Infection(7) Neutralizing antibodies(7) variant(7) COVID-19 patients(7) COVID-19 patient(7) ACE2(7) treating COVID-19 patient(7) effective(6) approach(6) Efficacy(6) cellular(6) addition(6) conditions(6) morbidity(6) coronavirus(6)